The purpose of this study is to determine the incidence of venous thromboembolism (
Inflammatory bowel disease is considered a risk factor for venous thromboembolism (VTE). 1 Two population-based investigations have shown an increased relative risk of VTE in patients hospitalized with ulcerative colitis. 2, 3 The largest study showed that the risk of VTE was higher in patients with ulcerative colitis than in patients with Crohn disease. 2 The incidence of VTE in patients with Crohn disease did not differ significantly from the incidence of VTE in hospitalized patients who did not have inflammatory bowel disease. 2 Others showed an incidence rate of deep venous thrombosis (DVT) that was similar with the 2 diseases, although the incidence of pulmonary embolism (PE) was higher in patients with ulcerative colitis. 3 Some showed no increased incidence of venous thrombosis among patients with inflammatory bowel disease. 4 In view of the importance of identifying medical patients who may require antithrombotic prophylaxis because of an increased risk of VTE, we assessed the incidence of VTE in hospitalized patients with ulcerative colitis and with Crohn disease using the database of the National Hospital Discharge Survey. 5 
Methods
The number of patients discharged from hospitals with a diagnostic code of ulcerative colitis from 1979 through 2005 was obtained from the National Hospital Discharge Survey. 5 Among these patients, the number with pulmonary embolism (PE), deep venous thrombosis (DVT), or VTE, defined as PE and/or DVT, was determined among patients who did not have bowel resection (medical patients). The National Hospital Discharge Survey consists of data obtained annually from approximately 270 000 sampled inpatient records from about 500 nonfederal short-stay hospitals (average length of stay <30 days) in 50 states and the District of Columbia. 5 The National Hospital Discharge Survey samples about 8% of short-stay nonfederals hospitals and about 1% of discharges.
Identification of Crohn Disease
The ICD-9-CM code used to identify Crohn disease was 555, which includes Crohn disease of the small and large intestine.
Identification of Bowel Resection
The ICD-9-CM codes used to identify the patients who underwent small or large bowel resection were 45.6 (multiple segmental resection of small intestine and other partial resection of small intestine), 45.7 (multiple segmental resection of large intestine, cecectomy, right hemicolectomy, resection of transverse colon, left hemicolectomy, sigmoidectomy, and other partial excision of large intestine), and 45.8 (total intraabdominal colectomy). None of the included patients with ulcerative colitis or Crohn disease and none of the control population had undergone a bowel resection during the hospitalization under consideration.
Identification of PE
The ICD-9-CM codes used for identification of patients with PE were 415.1, 634.6, 635.6, 636.6, 637.6, 638.6, and 673.2.
Identification of DVT
The ICD-9-CM codes used for DVT were 451.1, 451.2, 451.8, 451.9, 453.2, 453.8, 453.9, 671.3, 671.4, and 671.9. Five-digit codes, such as 451.11 (included under the code 451.1), were not listed as they were included under the corresponding 4-digit codes.
Statistical Analysis and Methodological Considerations
Chi square was used to assess differences of proportions (InStat version 3.0 GraphPad Software, San Diego, California). Relative risk and 95% CI were calculated using calculator for CIs of relative risk (www.sign.ac.uk/ methodology/risk.xls).
Results

Ulcerative Colitis
From 1979 to 2005, the incidence of VTE among patients with ulcerative colitis who had no bowel resection during that admission (which we define as medical patients) was 21 000 of 1 129 000 (1.86%; 95% CI ¼ 1.78%-1.94%). Among patients who had neither Crohn disease nor ulcerative colitis (no inflammatory bowel disease) and no bowel resection, the incidence of VTE was 10 421 000 of 918 570 000 (1.13%; 95% CI ¼ 1.11%-1.15%). The relative risk of VTE in medical patients, comparing those with ulcerative colitis with those who did not have inflammatory bowel disease, was 1.64 (95% CI ¼ 1.62-1.66). The relative risk of VTE was highest in patients younger than 40 years of age (2.96; 95% CI ¼ 2.88-3.04; Table 1 ).
The incidence of PE in hospitalized patients with ulcerative colitis who did not undergo bowel resection was 6000 of 1 129 000 (0.53%; 95% CI ¼ 0.49%-0.57%) and the incidence of PE in hospitalized patients who did not have Crohn disease, ulcerative colitis, or bowel resection was 3 483 000 of 918 570 000 (0.38%; 95% CI ¼ 0.37%-0.39%). The relative risk for PE was 1.40 (95% CI ¼ 1.37-1.44; Table 2 ). Deep venous thrombosis was diagnosed in 17 000 of 1 129 000 (1.51%; 95% CI ¼ 1.44%-1.58%) patients with ulcerative colitis who did not undergo a bowel resection and in 7 828 000 of 919 629 000 (0.85%; 95% CI ¼ 0.83%-0.87%) who did not have Crohn disease or ulcerative colitis or undergo a bowel resection. The relative risk of DVT, comparing ulcerative colitis patients with noninflammatory bowel patients, was 1.77 (95% CI ¼ 1.74-1.80; Table 2 ).
Among patients with ulcerative colitis, the relative risk of VTE in men was 1.60 and in women it was 1.68 ( Table 1 ). The vast majority of patients with ulcerative colitis were white. Data were insufficient to compare the incidence of VTE according to race.
Crohn Disease
The incidence of VTE among patients with Crohn disease and no bowel resection during that admission was 22 000 of Table 1 ). The incidence of PE in hospitalized patients with Crohn disease who did not undergo bowel resection was 5000 of 1 803 000 (0.28%; 95% CI ¼ 0.26%-0.30%), which was not greater than the incidence of PE in hospitalized medical patients who did not have inflammatory bowel disease, 3 483 000 of 918 570 000 (0.38%; 95% CI ¼ 0.37%-0.39%; relative risk 0.74; 95% CI ¼ 0.72-0.76). Deep venous thrombosis was diagnosed in 19 000 of 1 803 000 (1.05%; 95% CI ¼ 1.00%-1.10%) medical patients with Crohn disease and in 7 828 000 of 919 629 000 (0.85%; 95% CI ¼ 0.83%-0.87%) medical patients who did not have inflammatory bowel disease. The relative risk of DVT comparing medical patients with Crohn to medical patients who did not have inflammatory bowel disease was 1.24 (95% CI ¼ 1.22-1.26; Table 2 ).
Among patients with Crohn disease, the relative risk of VTE in men was 1.13 and in women it was 1.03 ( Table 2 ). The vast majority of patients with Crohn disease were white. Data were insufficient to compare the incidence of VTE according to race.
Ulcerative Colitis Versus Crohn Disease
Patients with ulcerative colitis compared with patients with Crohn disease had a higher relative risk for PE (relative risk 1.92), DVT (relative risk 1.43), and VTE (relative risk 1.52; Table 3 ).
We analyzed the relative risk of VTE from 2000 through 2005 in patients with ulcerative colitis and with Crohn disease to eliminate the effects of changing treatment over the years. During 2000-2005, the relative risk of VTE in patients with ulcerative colitis was 2.06 (95% CI ¼ 2.02-2.10) and the relative risk of VTE in patients with Crohn disease was 1.06 (95% CI ¼ 1.04-1.08).
The duration of hospitalization was similar in patients with ulcerative colitis and patients with Crohn disease. In patients with ulcerative colitis, 76% were hospitalized 8 days. In those with Crohn disease, 79% were hospitalized 8 days.
Discussion
Hospitalized medical patients with ulcerative colitis had higher incidence of VTE than patients who did not have inflammatory bowel diseases. The incidence of VTE was higher in patients with ulcerative colitis than in patients with Crohn disease. The relative risk of VTE in patients with Crohn disease was only marginally higher than in medical patients who did not have inflammatory bowel disease (relative risk ¼ 1.08).
The incidence of VTE in medical patients with ulcerative colitis that we report, 1.9%, was similar to the incidence in 38 800 nonbowel resection (medical) patients with ulcerative colitis reported by Nguyen et al, 1.95%, using data from the Nationwide Inpatient Sample. 2 The authors of this article and Nguyen et al showed a similar incidence of VTE in patients with Crohn disease and in hospitalized patients who did not have inflammatory bowel disease. The incidence of VTE in medical patients with Crohn disease that we report was 1.2%, and the incidence in medical patients who did not have inflammatory bowel disease was 1.1%. The incidence of VTE in all patients with Crohn reported by Nguyen et al (those who underwent bowel resection and those who did not) was 1.39%, and the incidence in those who did not have inflammatory bowel disease was 1.38%. 2 Nguyen et al reported that the incidence of VTE increased to 4.23% in patients with ulcerative colitis who underwent bowel resection and 2.11% in those with Crohn disease who underwent bowel resection. 2 The incidence of VTE also was higher in patients with Crohn disease who had abdominal fistulizing disease. We did not have sufficient data to determine the incidence of VTE in patients with ulcerative colitis or with Crohn disease who underwent bowel resection, and we did not have data on fistulizing disease in Crohn disease. Data from patients with ulcerative colitis in the Manitoba Health administrative database showed an incidence of VTE of 0.42% among 2857 patients hospitalized with Crohn disease and 0.50% among 2672 patients hospitalized with ulcerative colitis. 3 These incidences were lower than those reported by the authors of this article and Nguyen et al.
Among patients at a university hospital or a municipal hospital, 9 of 629 (1.4%) with ulcerative colitis and 7 of 620 (1.1%) with Crohn disease had VTE. 4 The incidence was the same as the incidence of VTE in the background population. The incidence of VTE in patients with Crohn disease that they observed was similar to the incidence that we observed, but the incidence with ulcerative colitis was lower than that we observed.
The relative risk of VTE in patients with ulcerative colitis was higher in patients younger than 40 years of age. This was also observed by others. 2, 3 Older patients often have associated disease that also may cause VTE.
The etiology of thromboembolic complications in patients with inflammatory bowel disease is thought to be multifactorial 6 and relates to acquired factors as well as inherited risk factors. 7 Patients with inflammatory bowel disease are thought to have both a prothrombotic condition and a hypercoagulable state. 6 A review by Papa et al 7 showed that only 2 of 14 studies reported differences in factor V Leiden carriers frequency among patients with Crohn disease and patients with ulcerative colitis.
We do not have clear explanation for the higher incidence of VTE in hospitalized patients with ulcerative colitis compared with those with Crohn disease. Perhaps, patients with ulcerative colitis had more extensive bowel involvement that those with Crohn disease. Solem et al 8 showed that patients with ulcerative colitis had pancolonic involvement in 45 of 59 (76%), whereas patients with Crohn disease had ileocolonic involvement in 22 of 39 (56%; P ¼ .39). The remainder of patents with Crohn disease had either colonic involvement, 9 of 39 (23%), or ileal involvement, 8 of 39 (21%). 8 A trend (not significant) showed a higher prevalence of thrombophilia in patients with ulcerative colitis, 28 of 59 (47%) compared with 12 of 39 (31%) in Crohn disease. 8 In our patients, the duration of hospitalization was similar in patients with ulcerative colitis and Crohn disease, so a longer duration of bed rest would not explain the difference in the incidence of VTE.
Strengths of this investigation are the large number of patients identified with ulcerative colitis (1 129 000 patients) and Crohn disease (1 803 000 patients) who did not undergo bowel resection during the admission in question, the diversity of the population in terms of age, race, gender, and geographic regions (all 50 states and the district of Columbia), the extensive duration of observation (27 years), and the meticulous and statistically robust methods of sampling. 5 Limitations include lack of data on the reason for hospitalization, proportion of patients hospitalized more than once, proportion of patients on bed rest, and the basis for the diagnosis of ulcerative colitis. Regarding the latter, however, it would seem unlikely that a discharge diagnosis of such a potentially devastating disease would be made without evidence. There may have been patients in whom Crohn disease or ulcerative colitis were not diagnosed. The validity of codes for bowel resection has been validated. 9 Regarding the robustness of discharge codes for DVT, White et al 10 showed that 92% of 198 coded cases of idiopathic DVT were valid. Regarding PE, review and reabstraction of a sample of Medicare hospitalizations from late 1986 and early 1989 showed that 92% of codable cases for PE were on the abstract. 11 A 0.4% prevalence of PE in hospitalized Caucasians and African Americans 20 years of age throughout the United States, based on the National Hospital Discharge Survey's use of ICD-9 codes, 12 was remarkably close to the prevalences of PE in a university hospital (0.4%), a nonuniversity tertiary care center (excluding estimates of undiagnosed PE in patients who died; 0.4%), and a community/teaching hospital (0.3%). 12, 13 These incidences were based on review of multiple data sources including radiographic reports and autopsies (but not including estimates of unsuspected deaths from PE when no autopsy was performed). [12] [13] [14] In conclusion, the risk of VTE is increased in hospitalized medical patients with ulcerative colitis, but only marginally increased in those with Crohn disease.
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